Free Trial

Prudential Financial Inc. Sells 5,166 Shares of Novanta Inc. (NASDAQ:NOVT)

Novanta logo with Computer and Technology background
Remove Ads

Prudential Financial Inc. lessened its holdings in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) by 60.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,439 shares of the technology company's stock after selling 5,166 shares during the period. Prudential Financial Inc.'s holdings in Novanta were worth $576,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Empowered Funds LLC bought a new position in Novanta during the 4th quarter worth $26,000. SBI Securities Co. Ltd. bought a new stake in Novanta during the fourth quarter worth about $97,000. Venturi Wealth Management LLC grew its stake in Novanta by 6,500.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company's stock worth $111,000 after buying an additional 715 shares in the last quarter. KBC Group NV increased its holdings in Novanta by 41.6% in the 4th quarter. KBC Group NV now owns 1,500 shares of the technology company's stock valued at $229,000 after buying an additional 441 shares during the period. Finally, Sanctuary Advisors LLC acquired a new position in shares of Novanta in the 3rd quarter valued at approximately $232,000. 98.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Robert W. Baird decreased their price objective on shares of Novanta from $169.00 to $160.00 and set a "neutral" rating on the stock in a research note on Monday, March 3rd.

Check Out Our Latest Stock Report on Novanta

Remove Ads

Novanta Price Performance

NOVT stock traded up $1.39 during trading on Friday, reaching $112.39. 412,445 shares of the company were exchanged, compared to its average volume of 192,768. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of 67.30 and a beta of 1.42. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81. The company has a 50-day moving average of $134.67 and a two-hundred day moving average of $153.70. Novanta Inc. has a twelve month low of $98.76 and a twelve month high of $187.12.

Novanta (NASDAQ:NOVT - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The technology company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.05. Novanta had a net margin of 6.52% and a return on equity of 15.20%. The company had revenue of $238.10 million during the quarter, compared to the consensus estimate of $240.29 million. During the same period in the prior year, the business earned $0.63 earnings per share. The company's revenue for the quarter was up 12.5% compared to the same quarter last year. As a group, equities analysts predict that Novanta Inc. will post 3.03 earnings per share for the current fiscal year.

Novanta Company Profile

(Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Featured Stories

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads